Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(oncolytic virotherapy). Showing records 1 – 30 of 38 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

Levels

▼ Search Limiters


University of Newcastle

1. Chan, Eric. Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma.

Degree: PhD, 2014, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Malignant gliomas (MGs) are the most common tumours of the central nervous system (CNS) and respond poorly to… (more)

Subjects/Keywords: oncolytic virotherapy; malignant glioma; chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chan, E. (2014). Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1050162

Chicago Manual of Style (16th Edition):

Chan, Eric. “Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma.” 2014. Doctoral Dissertation, University of Newcastle. Accessed April 14, 2021. http://hdl.handle.net/1959.13/1050162.

MLA Handbook (7th Edition):

Chan, Eric. “Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma.” 2014. Web. 14 Apr 2021.

Vancouver:

Chan E. Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma. [Internet] [Doctoral dissertation]. University of Newcastle; 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1959.13/1050162.

Council of Science Editors:

Chan E. Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma. [Doctoral Dissertation]. University of Newcastle; 2014. Available from: http://hdl.handle.net/1959.13/1050162


University of Guelph

2. AuYeung, Wing Ka Amanda. Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma.

Degree: MS, Department of Pathobiology, 2017, University of Guelph

 Conventional therapies have demonstrated little to no extension in overall survival in the context of metastatic melanomas. As a result there is growing interest in… (more)

Subjects/Keywords: oncolytic virotherapy; cancer immunotherapy; melanoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

AuYeung, W. K. A. (2017). Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma. (Masters Thesis). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/11517

Chicago Manual of Style (16th Edition):

AuYeung, Wing Ka Amanda. “Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma.” 2017. Masters Thesis, University of Guelph. Accessed April 14, 2021. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/11517.

MLA Handbook (7th Edition):

AuYeung, Wing Ka Amanda. “Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma.” 2017. Web. 14 Apr 2021.

Vancouver:

AuYeung WKA. Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma. [Internet] [Masters thesis]. University of Guelph; 2017. [cited 2021 Apr 14]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/11517.

Council of Science Editors:

AuYeung WKA. Immunological effects of oncolytic virotherapy in the context of a preclinical model of melanoma. [Masters Thesis]. University of Guelph; 2017. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/11517


University of Newcastle

3. Smith, Lincoln. Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer.

Degree: PhD, 2018, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Coxsackievirus A21 (CVA21) is a human specific, non-enveloped, 28 nm icosahedral, group C enterovirus with a single strand… (more)

Subjects/Keywords: coxsackievirus A21; CVA21; pancreatic cancer; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, L. (2018). Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1391435

Chicago Manual of Style (16th Edition):

Smith, Lincoln. “Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer.” 2018. Doctoral Dissertation, University of Newcastle. Accessed April 14, 2021. http://hdl.handle.net/1959.13/1391435.

MLA Handbook (7th Edition):

Smith, Lincoln. “Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer.” 2018. Web. 14 Apr 2021.

Vancouver:

Smith L. Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer. [Internet] [Doctoral dissertation]. University of Newcastle; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1959.13/1391435.

Council of Science Editors:

Smith L. Investigation of coxsackievirus A21 as a potential treatment for pancreatic cancer. [Doctoral Dissertation]. University of Newcastle; 2018. Available from: http://hdl.handle.net/1959.13/1391435


University of Minnesota

4. Berg, David. A Flexible Simulator for Oncolytic Viral Therapy.

Degree: MS, Biomedical Informatics and Computational Biology, 2015, University of Minnesota

 Developments in recombinant DNA technology have given researchers the ability to modify viruses so that they are highly selective towards cancer cells. Engineered viruses have… (more)

Subjects/Keywords: cancer; measles; monte carlo; oncolytic; simulation; virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Berg, D. (2015). A Flexible Simulator for Oncolytic Viral Therapy. (Masters Thesis). University of Minnesota. Retrieved from http://hdl.handle.net/11299/174710

Chicago Manual of Style (16th Edition):

Berg, David. “A Flexible Simulator for Oncolytic Viral Therapy.” 2015. Masters Thesis, University of Minnesota. Accessed April 14, 2021. http://hdl.handle.net/11299/174710.

MLA Handbook (7th Edition):

Berg, David. “A Flexible Simulator for Oncolytic Viral Therapy.” 2015. Web. 14 Apr 2021.

Vancouver:

Berg D. A Flexible Simulator for Oncolytic Viral Therapy. [Internet] [Masters thesis]. University of Minnesota; 2015. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/11299/174710.

Council of Science Editors:

Berg D. A Flexible Simulator for Oncolytic Viral Therapy. [Masters Thesis]. University of Minnesota; 2015. Available from: http://hdl.handle.net/11299/174710


Louisiana State University

5. Fowlkes, Natalie Wall. Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model.

Degree: PhD, Comparative and Laboratory Animal Medicine, 2018, Louisiana State University

  Melanoma accounts for 90% of skin cancer-related deaths in humans. Treatment options for metastatic melanoma in people is very limited. Melanoma is considered to… (more)

Subjects/Keywords: melanoma; cancer model; oncolytic virotherapy; HSV-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fowlkes, N. W. (2018). Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model. (Doctoral Dissertation). Louisiana State University. Retrieved from https://digitalcommons.lsu.edu/gradschool_dissertations/4669

Chicago Manual of Style (16th Edition):

Fowlkes, Natalie Wall. “Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model.” 2018. Doctoral Dissertation, Louisiana State University. Accessed April 14, 2021. https://digitalcommons.lsu.edu/gradschool_dissertations/4669.

MLA Handbook (7th Edition):

Fowlkes, Natalie Wall. “Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model.” 2018. Web. 14 Apr 2021.

Vancouver:

Fowlkes NW. Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model. [Internet] [Doctoral dissertation]. Louisiana State University; 2018. [cited 2021 Apr 14]. Available from: https://digitalcommons.lsu.edu/gradschool_dissertations/4669.

Council of Science Editors:

Fowlkes NW. Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model. [Doctoral Dissertation]. Louisiana State University; 2018. Available from: https://digitalcommons.lsu.edu/gradschool_dissertations/4669


University of Newcastle

6. Quah, Min Yuan. Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma.

Degree: PhD, 2016, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Malignant melanoma is one of the most aggressive and lethal cancers of the skin. Clinical reports have shown… (more)

Subjects/Keywords: chemotherapy; melanoma; oncolytic coxsackievirus A21; skin cancers; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Quah, M. Y. (2016). Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1312749

Chicago Manual of Style (16th Edition):

Quah, Min Yuan. “Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma.” 2016. Doctoral Dissertation, University of Newcastle. Accessed April 14, 2021. http://hdl.handle.net/1959.13/1312749.

MLA Handbook (7th Edition):

Quah, Min Yuan. “Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma.” 2016. Web. 14 Apr 2021.

Vancouver:

Quah MY. Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma. [Internet] [Doctoral dissertation]. University of Newcastle; 2016. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1959.13/1312749.

Council of Science Editors:

Quah MY. Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma. [Doctoral Dissertation]. University of Newcastle; 2016. Available from: http://hdl.handle.net/1959.13/1312749


University of Newcastle

7. Wong, Yvonne Vern Yee. Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer.

Degree: PhD, 2016, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Lung cancer is the most frequently diagnosed and the second most common mortalityrelated cancer in the world, with… (more)

Subjects/Keywords: oncolytic coxsackievirus A21; lung cancer; mortalityrelated cancer; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wong, Y. V. Y. (2016). Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1314627

Chicago Manual of Style (16th Edition):

Wong, Yvonne Vern Yee. “Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer.” 2016. Doctoral Dissertation, University of Newcastle. Accessed April 14, 2021. http://hdl.handle.net/1959.13/1314627.

MLA Handbook (7th Edition):

Wong, Yvonne Vern Yee. “Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer.” 2016. Web. 14 Apr 2021.

Vancouver:

Wong YVY. Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer. [Internet] [Doctoral dissertation]. University of Newcastle; 2016. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1959.13/1314627.

Council of Science Editors:

Wong YVY. Investigation of oncolytic coxsackievirus A21 as a potential treatment for lung cancer. [Doctoral Dissertation]. University of Newcastle; 2016. Available from: http://hdl.handle.net/1959.13/1314627


University of Miami

8. Heiber, Joshua F. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.

Degree: PhD, Microbiology and Immunology (Medicine), 2011, University of Miami

Oncolytic virotherapy is emerging as a new treatment option for cancer patients. At present, there are relatively few oncolytic virus clinical trials that are underway… (more)

Subjects/Keywords: Vesicular Stomatits Virus; p53, oncolytic virus, oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Heiber, J. F. (2011). Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. (Doctoral Dissertation). University of Miami. Retrieved from https://scholarlyrepository.miami.edu/oa_dissertations/600

Chicago Manual of Style (16th Edition):

Heiber, Joshua F. “Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.” 2011. Doctoral Dissertation, University of Miami. Accessed April 14, 2021. https://scholarlyrepository.miami.edu/oa_dissertations/600.

MLA Handbook (7th Edition):

Heiber, Joshua F. “Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector.” 2011. Web. 14 Apr 2021.

Vancouver:

Heiber JF. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. [Internet] [Doctoral dissertation]. University of Miami; 2011. [cited 2021 Apr 14]. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/600.

Council of Science Editors:

Heiber JF. Characterization and Development of Vesicular Stomatitis Virus For Use as an Oncolytic Vector. [Doctoral Dissertation]. University of Miami; 2011. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/600


University of Oxford

9. Thoma, Clemens Matthias Manuel. Improving intraperitoneal adenovirus virotherapy for ovarian cancer.

Degree: PhD, 2011, University of Oxford

 The use of intraperitoneal (i.p.) adenovirus virotherapy of ovarian cancer is currently limited by insufficient efficacy and high toxicity. Both factors are associated with adenovirus… (more)

Subjects/Keywords: 616.99465; Oncology; Medical sciences; Tumours; Viruses; Gynaecology; ovarian cancer; oncolytic; oncolytic virotherapy; adenovirus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thoma, C. M. M. (2011). Improving intraperitoneal adenovirus virotherapy for ovarian cancer. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:841e4334-f408-4da3-b8e6-1d29350c5304 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559781

Chicago Manual of Style (16th Edition):

Thoma, Clemens Matthias Manuel. “Improving intraperitoneal adenovirus virotherapy for ovarian cancer.” 2011. Doctoral Dissertation, University of Oxford. Accessed April 14, 2021. http://ora.ox.ac.uk/objects/uuid:841e4334-f408-4da3-b8e6-1d29350c5304 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559781.

MLA Handbook (7th Edition):

Thoma, Clemens Matthias Manuel. “Improving intraperitoneal adenovirus virotherapy for ovarian cancer.” 2011. Web. 14 Apr 2021.

Vancouver:

Thoma CMM. Improving intraperitoneal adenovirus virotherapy for ovarian cancer. [Internet] [Doctoral dissertation]. University of Oxford; 2011. [cited 2021 Apr 14]. Available from: http://ora.ox.ac.uk/objects/uuid:841e4334-f408-4da3-b8e6-1d29350c5304 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559781.

Council of Science Editors:

Thoma CMM. Improving intraperitoneal adenovirus virotherapy for ovarian cancer. [Doctoral Dissertation]. University of Oxford; 2011. Available from: http://ora.ox.ac.uk/objects/uuid:841e4334-f408-4da3-b8e6-1d29350c5304 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559781


University of Oxford

10. Dyer, Arthur Jack. Exploring the relationship between cancer metabolism and oncolytic adenoviruses.

Degree: PhD, 2021, University of Oxford

 Tumour cells exhibiting the Warburg effect rely mostly upon aerobic glycolysis for ATP production and have a notable addiction to anaplerotic use of glutamine for… (more)

Subjects/Keywords: Virology; Metabolism; tumour metabolism; Cancer – Immunotherapy; Oncology; oncolytic virotherapy; Gene therapy; oncolytic

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dyer, A. J. (2021). Exploring the relationship between cancer metabolism and oncolytic adenoviruses. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:3f065eed-9473-4e7b-8806-be34611eb600 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.823620

Chicago Manual of Style (16th Edition):

Dyer, Arthur Jack. “Exploring the relationship between cancer metabolism and oncolytic adenoviruses.” 2021. Doctoral Dissertation, University of Oxford. Accessed April 14, 2021. http://ora.ox.ac.uk/objects/uuid:3f065eed-9473-4e7b-8806-be34611eb600 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.823620.

MLA Handbook (7th Edition):

Dyer, Arthur Jack. “Exploring the relationship between cancer metabolism and oncolytic adenoviruses.” 2021. Web. 14 Apr 2021.

Vancouver:

Dyer AJ. Exploring the relationship between cancer metabolism and oncolytic adenoviruses. [Internet] [Doctoral dissertation]. University of Oxford; 2021. [cited 2021 Apr 14]. Available from: http://ora.ox.ac.uk/objects/uuid:3f065eed-9473-4e7b-8806-be34611eb600 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.823620.

Council of Science Editors:

Dyer AJ. Exploring the relationship between cancer metabolism and oncolytic adenoviruses. [Doctoral Dissertation]. University of Oxford; 2021. Available from: http://ora.ox.ac.uk/objects/uuid:3f065eed-9473-4e7b-8806-be34611eb600 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.823620


University of Ottawa

11. Allan, Kristina Jean. Enhancing Oncolytic Virotherapy Using Functional Genomic Screening .

Degree: 2018, University of Ottawa

At the author’s request, the abstract has been removed due to the confidential nature of the thesis. It will be added once the embargo period has passed.

Subjects/Keywords: oncolytic; virotherapy; cancer; RNAi; vaccinia; screen; high-throughput

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Allan, K. J. (2018). Enhancing Oncolytic Virotherapy Using Functional Genomic Screening . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/37910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Allan, Kristina Jean. “Enhancing Oncolytic Virotherapy Using Functional Genomic Screening .” 2018. Thesis, University of Ottawa. Accessed April 14, 2021. http://hdl.handle.net/10393/37910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Allan, Kristina Jean. “Enhancing Oncolytic Virotherapy Using Functional Genomic Screening .” 2018. Web. 14 Apr 2021.

Vancouver:

Allan KJ. Enhancing Oncolytic Virotherapy Using Functional Genomic Screening . [Internet] [Thesis]. University of Ottawa; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10393/37910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Allan KJ. Enhancing Oncolytic Virotherapy Using Functional Genomic Screening . [Thesis]. University of Ottawa; 2018. Available from: http://hdl.handle.net/10393/37910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

12. Ho, Tiffany Yun-Yee. Designing the Next-generation Oncolytic Vaccinia Virus.

Degree: 2017, University of Toronto

Many oncolytic viruses (OVs), such as double-deleted vaccina virus (vvDD), are engineered with enhanced tumor-selectivity based on increased cell proliferation in cancer cells. We proposed… (more)

Subjects/Keywords: Cancer therapy; Interferon; Oncolytic virotherapy; Peritoneal Carcinomatosis; Vaccinia Virus; vvDD; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ho, T. Y. (2017). Designing the Next-generation Oncolytic Vaccinia Virus. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/77794

Chicago Manual of Style (16th Edition):

Ho, Tiffany Yun-Yee. “Designing the Next-generation Oncolytic Vaccinia Virus.” 2017. Masters Thesis, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/77794.

MLA Handbook (7th Edition):

Ho, Tiffany Yun-Yee. “Designing the Next-generation Oncolytic Vaccinia Virus.” 2017. Web. 14 Apr 2021.

Vancouver:

Ho TY. Designing the Next-generation Oncolytic Vaccinia Virus. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/77794.

Council of Science Editors:

Ho TY. Designing the Next-generation Oncolytic Vaccinia Virus. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/77794

13. Clarkin, Ryan Gregory. Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein .

Degree: 2018, University of Ottawa

 Conditionally-replicating adenoviruses (CRAds) have generally demonstrated only modest therapeutic efficacy in human clinical trials, in part due to their poor ability to spread throughout a… (more)

Subjects/Keywords: Cancer; Adenovirus; Oncolytic; Virotherapy

…improving our ability to treat, and in some cases, cure cancer. 1 1.2. Oncolytic virotherapy… …for cancer treatment Oncolytic virotherapy is an emerging cancer treatment that uses… …field of oncolytic virotherapy was somewhat limited until the 1990s, when researchers began… …x29;. Killing of cancer cells by oncolytic viruses can occur through several different… …genetically engineered oncolytic viruses can be “armed” with therapeutic transgenes to enhance anti… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clarkin, R. G. (2018). Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/38379

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Clarkin, Ryan Gregory. “Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein .” 2018. Thesis, University of Ottawa. Accessed April 14, 2021. http://hdl.handle.net/10393/38379.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Clarkin, Ryan Gregory. “Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein .” 2018. Web. 14 Apr 2021.

Vancouver:

Clarkin RG. Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein . [Internet] [Thesis]. University of Ottawa; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10393/38379.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Clarkin RG. Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein . [Thesis]. University of Ottawa; 2018. Available from: http://hdl.handle.net/10393/38379

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Guelph

14. Syed, Zafir. The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas.

Degree: MS, Department of Pathobiology, 2014, University of Guelph

 Survival of patients with high-grade gliomas is dismal. Oncolytic viruses (OV) and histone deacetylase inhibitors (HDIs) represent revolutionary approaches to treating cancers, with minimal toxic… (more)

Subjects/Keywords: oncolytic virotherapy; histone deacetylase inhibitor; brain cancer; glioma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Syed, Z. (2014). The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas. (Masters Thesis). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8291

Chicago Manual of Style (16th Edition):

Syed, Zafir. “The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas.” 2014. Masters Thesis, University of Guelph. Accessed April 14, 2021. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8291.

MLA Handbook (7th Edition):

Syed, Zafir. “The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas.” 2014. Web. 14 Apr 2021.

Vancouver:

Syed Z. The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas. [Internet] [Masters thesis]. University of Guelph; 2014. [cited 2021 Apr 14]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8291.

Council of Science Editors:

Syed Z. The Combination of Histone Deacetylase Inhibitors and Oncolytic Viruses for the treatment of High-grade Gliomas. [Masters Thesis]. University of Guelph; 2014. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8291


University of Guelph

15. Ternamian, Christian. Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition.

Degree: MS, Department of Pathobiology, 2014, University of Guelph

 B-cell acute lymphoblastic leukemia (B-ALL) is a hematological disease characterized by the proliferation and extramedullary distribution of malignant B lymphoblasts. Though conventional treatment can be… (more)

Subjects/Keywords: Oncolytic Virotherapy; Histone deacetylase inhibitor; L1210; CD45; Leukemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ternamian, C. (2014). Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition. (Masters Thesis). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8293

Chicago Manual of Style (16th Edition):

Ternamian, Christian. “Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition.” 2014. Masters Thesis, University of Guelph. Accessed April 14, 2021. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8293.

MLA Handbook (7th Edition):

Ternamian, Christian. “Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition.” 2014. Web. 14 Apr 2021.

Vancouver:

Ternamian C. Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition. [Internet] [Masters thesis]. University of Guelph; 2014. [cited 2021 Apr 14]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8293.

Council of Science Editors:

Ternamian C. Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition. [Masters Thesis]. University of Guelph; 2014. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8293


University of Oxford

16. Cooper, Lisa May. Bioprocessing of oncolytic group B adenovirus for scalable production.

Degree: PhD, 2014, University of Oxford

 The central aim of this thesis was to develop strategies to improve the manufacture of the group B chimeric oncolytic adenovirus, ColoAd1, which rapidly kills… (more)

Subjects/Keywords: 616.99; bioprocessing; cancer; adenovirus; oncolytic; replication; virotherapy; metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cooper, L. M. (2014). Bioprocessing of oncolytic group B adenovirus for scalable production. (Doctoral Dissertation). University of Oxford. Retrieved from https://ora.ox.ac.uk/objects/uuid:bc62bd13-f43f-4d35-8975-7fc341ce209c ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711758

Chicago Manual of Style (16th Edition):

Cooper, Lisa May. “Bioprocessing of oncolytic group B adenovirus for scalable production.” 2014. Doctoral Dissertation, University of Oxford. Accessed April 14, 2021. https://ora.ox.ac.uk/objects/uuid:bc62bd13-f43f-4d35-8975-7fc341ce209c ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711758.

MLA Handbook (7th Edition):

Cooper, Lisa May. “Bioprocessing of oncolytic group B adenovirus for scalable production.” 2014. Web. 14 Apr 2021.

Vancouver:

Cooper LM. Bioprocessing of oncolytic group B adenovirus for scalable production. [Internet] [Doctoral dissertation]. University of Oxford; 2014. [cited 2021 Apr 14]. Available from: https://ora.ox.ac.uk/objects/uuid:bc62bd13-f43f-4d35-8975-7fc341ce209c ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711758.

Council of Science Editors:

Cooper LM. Bioprocessing of oncolytic group B adenovirus for scalable production. [Doctoral Dissertation]. University of Oxford; 2014. Available from: https://ora.ox.ac.uk/objects/uuid:bc62bd13-f43f-4d35-8975-7fc341ce209c ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711758


University of Adelaide

17. Singleton, Eve Victoria. Sterility and immunogenicity of gamma-irradiated respiratory viruses.

Degree: 2020, University of Adelaide

 Gamma (γ)-radiation is a method commonly applied to sterilise pathogens in the biomedical, food and pharmaceutical industries. γ-radiation inactivates pathogens by causing irreparable damage to… (more)

Subjects/Keywords: Gamma radiation; Influenza A virus; Newcastle disease virus; vaccine; oncolytic virotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Singleton, E. V. (2020). Sterility and immunogenicity of gamma-irradiated respiratory viruses. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/128819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Singleton, Eve Victoria. “Sterility and immunogenicity of gamma-irradiated respiratory viruses.” 2020. Thesis, University of Adelaide. Accessed April 14, 2021. http://hdl.handle.net/2440/128819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Singleton, Eve Victoria. “Sterility and immunogenicity of gamma-irradiated respiratory viruses.” 2020. Web. 14 Apr 2021.

Vancouver:

Singleton EV. Sterility and immunogenicity of gamma-irradiated respiratory viruses. [Internet] [Thesis]. University of Adelaide; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2440/128819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Singleton EV. Sterility and immunogenicity of gamma-irradiated respiratory viruses. [Thesis]. University of Adelaide; 2020. Available from: http://hdl.handle.net/2440/128819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Urbana-Champaign

18. Thomas, Diana L. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.

Degree: PhD, 0323, 2011, University of Illinois – Urbana-Champaign

 Adoptive immunotherapy and oncolytic virotherapy are two promising strategies for treating primary and metastatic malignant brain tumors. We demonstrate the ability of adoptively transferred tumor-specific… (more)

Subjects/Keywords: brain tumors; immunotherapy; oncolytic virotherapy; Melanoma; Adoptive T Cell Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thomas, D. L. (2011). Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/18568

Chicago Manual of Style (16th Edition):

Thomas, Diana L. “Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.” 2011. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed April 14, 2021. http://hdl.handle.net/2142/18568.

MLA Handbook (7th Edition):

Thomas, Diana L. “Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.” 2011. Web. 14 Apr 2021.

Vancouver:

Thomas DL. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2011. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2142/18568.

Council of Science Editors:

Thomas DL. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2011. Available from: http://hdl.handle.net/2142/18568


Arizona State University

19. Kasimsetty, Aradhana. Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy.

Degree: Biology, 2020, Arizona State University

 Since the molecular biology revolution in the 1980s, ease of gene editing had led to the resurgence of Oncolytic Virotherapy. Countless viruses have been engineered… (more)

Subjects/Keywords: Virology; Oncology; Immunology; E3L; Necroptosis; Oncolytic Virotherapy; RIP3; RIP3K; Vaccinia Virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kasimsetty, A. (2020). Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy. (Masters Thesis). Arizona State University. Retrieved from http://repository.asu.edu/items/57343

Chicago Manual of Style (16th Edition):

Kasimsetty, Aradhana. “Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy.” 2020. Masters Thesis, Arizona State University. Accessed April 14, 2021. http://repository.asu.edu/items/57343.

MLA Handbook (7th Edition):

Kasimsetty, Aradhana. “Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy.” 2020. Web. 14 Apr 2021.

Vancouver:

Kasimsetty A. Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy. [Internet] [Masters thesis]. Arizona State University; 2020. [cited 2021 Apr 14]. Available from: http://repository.asu.edu/items/57343.

Council of Science Editors:

Kasimsetty A. Characterization of the Role of Necroptosis for Oncolytic Vaccinia Efficacy. [Masters Thesis]. Arizona State University; 2020. Available from: http://repository.asu.edu/items/57343


INP Toulouse

20. Ricordel, Marine. Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution.

Degree: Docteur es, Pathologie, Toxicologie, Génétique et Nutrition, 2018, INP Toulouse

Les virus oncolytiques sont une nouvelle classe d’agents thérapeutiques pouvant être une alternative au traitement des cancers. Plusieurs virus oncolytiques sont actuellement développés en clinique,… (more)

Subjects/Keywords: Poxvirus; Virothérapie oncolytique; Tropisme tumoral; Evolution dirigée; Poxviruses; Oncolytic virotherapy; Tropism modification; Directed evolution

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ricordel, M. (2018). Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution. (Doctoral Dissertation). INP Toulouse. Retrieved from http://www.theses.fr/2018INPT0010

Chicago Manual of Style (16th Edition):

Ricordel, Marine. “Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution.” 2018. Doctoral Dissertation, INP Toulouse. Accessed April 14, 2021. http://www.theses.fr/2018INPT0010.

MLA Handbook (7th Edition):

Ricordel, Marine. “Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution.” 2018. Web. 14 Apr 2021.

Vancouver:

Ricordel M. Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution. [Internet] [Doctoral dissertation]. INP Toulouse; 2018. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2018INPT0010.

Council of Science Editors:

Ricordel M. Sélection, Génération et Amélioration de Poxvirus Oncolytiques par Génie Génétique et Evolution Dirigée : Selection, generation and improvement of oncolytic poxviruses with viral engineering and directed evolution. [Doctoral Dissertation]. INP Toulouse; 2018. Available from: http://www.theses.fr/2018INPT0010

21. Betancourt, Dillon M. Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies.

Degree: PhD, Microbiology and Immunology (Medicine), 2017, University of Miami

Oncolytic virotherapy is an exciting field that is currently generating a significant amount of interest. Several viruses have recently been approved for clinical use… (more)

Subjects/Keywords: VSV; cancer; oncolytic virotherapy; ATL

…ANCIENT DISEASE TO MODERN TIMES …. 1 2 ONCOLYTIC VIROTHERAPY: RECRUITING VIRUSES TO… …ONCOLYTIC VECTOR ….......................................................................... 55… …4 RETARGETING ONCOLYTIC VESICULAR STOMATITIS VIRUS TO HUMAN T-CELL LYMPHOTROPIC VIRUS… …VSV-gp160G remains potently oncolytic page 88 Figure 4.3 VSV-gp160G is specific for… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Betancourt, D. M. (2017). Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies. (Doctoral Dissertation). University of Miami. Retrieved from https://scholarlyrepository.miami.edu/oa_dissertations/1873

Chicago Manual of Style (16th Edition):

Betancourt, Dillon M. “Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies.” 2017. Doctoral Dissertation, University of Miami. Accessed April 14, 2021. https://scholarlyrepository.miami.edu/oa_dissertations/1873.

MLA Handbook (7th Edition):

Betancourt, Dillon M. “Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies.” 2017. Web. 14 Apr 2021.

Vancouver:

Betancourt DM. Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies. [Internet] [Doctoral dissertation]. University of Miami; 2017. [cited 2021 Apr 14]. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/1873.

Council of Science Editors:

Betancourt DM. Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies. [Doctoral Dissertation]. University of Miami; 2017. Available from: https://scholarlyrepository.miami.edu/oa_dissertations/1873


University of Oxford

22. Cawood, Ryan. Liver specific microRNA control of adenovirus serotype five.

Degree: PhD, 2011, University of Oxford

 MicroRNAs are small non-coding RNA molecules that regulate mRNA translation by binding to complementary sequences usually within the 3’ un-translated region (UTR). By inserting four… (more)

Subjects/Keywords: 615.1; Gene medicine; Medical Sciences; Biology (medical sciences); Oncology; Viruses; Biology; microRNA; virotherapy; oncolytic; adenovirus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cawood, R. (2011). Liver specific microRNA control of adenovirus serotype five. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:d97d80b5-6272-4aab-b555-d03d0016eeff ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543557

Chicago Manual of Style (16th Edition):

Cawood, Ryan. “Liver specific microRNA control of adenovirus serotype five.” 2011. Doctoral Dissertation, University of Oxford. Accessed April 14, 2021. http://ora.ox.ac.uk/objects/uuid:d97d80b5-6272-4aab-b555-d03d0016eeff ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543557.

MLA Handbook (7th Edition):

Cawood, Ryan. “Liver specific microRNA control of adenovirus serotype five.” 2011. Web. 14 Apr 2021.

Vancouver:

Cawood R. Liver specific microRNA control of adenovirus serotype five. [Internet] [Doctoral dissertation]. University of Oxford; 2011. [cited 2021 Apr 14]. Available from: http://ora.ox.ac.uk/objects/uuid:d97d80b5-6272-4aab-b555-d03d0016eeff ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543557.

Council of Science Editors:

Cawood R. Liver specific microRNA control of adenovirus serotype five. [Doctoral Dissertation]. University of Oxford; 2011. Available from: http://ora.ox.ac.uk/objects/uuid:d97d80b5-6272-4aab-b555-d03d0016eeff ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543557


Stellenbosch University

23. Winnie Wanja, Chabaari. Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system.

Degree: MSc, Mathematical Sciences, 2019, Stellenbosch University

ENGLISH ABSTRACT: Lately, oncolytic viruses have been used to mitigate cancer as they lyse tumor cells whilst leaving normal cells largely unharmed (as opposed to… (more)

Subjects/Keywords: Oncolytic virotherapy  – Mathematical models; Delay differential equations; MATLAB; Immuno response  – Simulation methods; Cancer  – Treatment  – Mathematical models; Virusses  – Therapeutic use; Virotherapy  – Mathematical models

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Winnie Wanja, C. (2019). Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system. (Masters Thesis). Stellenbosch University. Retrieved from http://hdl.handle.net/10019.1/106928

Chicago Manual of Style (16th Edition):

Winnie Wanja, Chabaari. “Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system.” 2019. Masters Thesis, Stellenbosch University. Accessed April 14, 2021. http://hdl.handle.net/10019.1/106928.

MLA Handbook (7th Edition):

Winnie Wanja, Chabaari. “Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system.” 2019. Web. 14 Apr 2021.

Vancouver:

Winnie Wanja C. Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system. [Internet] [Masters thesis]. Stellenbosch University; 2019. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10019.1/106928.

Council of Science Editors:

Winnie Wanja C. Intracellular and immune-response delays effects on the interation between tumor cells, oncolytic viruses and the immune system. [Masters Thesis]. Stellenbosch University; 2019. Available from: http://hdl.handle.net/10019.1/106928

24. Saloura, Vassiliki. Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος.

Degree: 2017, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

 The results of the described research projects support that the oncolytic virus VSV.IFN-β manifests remarkable anticancer effects against mesothelioma cancer cells and this is mediated… (more)

Subjects/Keywords: κακόηθες μεσοθηλίωμα; Γονιδιακή θεραπεία; ογκολυτική ιοθεραπεία; ιός θυλακιώδους στοματίτιδας; Malignant mesothelioma; Gene therapy; Oncolytic virotherapy; Vesicular stomatitis virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saloura, V. (2017). Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/42194

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Saloura, Vassiliki. “Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος.” 2017. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/42194.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Saloura, Vassiliki. “Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος.” 2017. Web. 14 Apr 2021.

Vancouver:

Saloura V. Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/42194.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Saloura V. Ο ρόλος των ιών ως φορέων στη γονιδιακή θεραπεία του κακοήθους μεσοθηλιώματος. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. Available from: http://hdl.handle.net/10442/hedi/42194

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Stellenbosch University

25. Mahasa, Khaphetsi Joseph. Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy.

Degree: PhD, Mathematical Sciences, 2017, Stellenbosch University

ENGLISH ABSTRACT : The immune system plays a key role against the development and progression of tumor cells mainly because of its capability of recognizing… (more)

Subjects/Keywords: Immune system  – Surveillance; Medical research  – Mathematical models; Mathematical models  – Differential equations; Cancer  – Treatment  – Mathematical models; Oncolytic virotherapy; Tumors  – Immunological aspects

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mahasa, K. J. (2017). Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy. (Doctoral Dissertation). Stellenbosch University. Retrieved from http://hdl.handle.net/10019.1/102597

Chicago Manual of Style (16th Edition):

Mahasa, Khaphetsi Joseph. “Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy.” 2017. Doctoral Dissertation, Stellenbosch University. Accessed April 14, 2021. http://hdl.handle.net/10019.1/102597.

MLA Handbook (7th Edition):

Mahasa, Khaphetsi Joseph. “Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy.” 2017. Web. 14 Apr 2021.

Vancouver:

Mahasa KJ. Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy. [Internet] [Doctoral dissertation]. Stellenbosch University; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10019.1/102597.

Council of Science Editors:

Mahasa KJ. Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy. [Doctoral Dissertation]. Stellenbosch University; 2017. Available from: http://hdl.handle.net/10019.1/102597


University of Oxford

26. Kueberuwa, Gray L. B. Development of sindbis virus as an oncolytic agent.

Degree: PhD, 2012, University of Oxford

 The poor stability of most therapeutic viruses in the human bloodstream is a major obstacle in the field of cancer virotherapy, preventing systemic intravenous delivery… (more)

Subjects/Keywords: 616.9; Oncology; Pharmacology; Viruses; Biology (medical sciences); Tumour pathology; Infectious diseases; Clinical microbiology; Blood; Oncolytic; Virotherapy; MicroRNA; Pharmacokinetics; Virology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kueberuwa, G. L. B. (2012). Development of sindbis virus as an oncolytic agent. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:d9737357-ab86-4baf-92a9-b4a21b615fd7 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580968

Chicago Manual of Style (16th Edition):

Kueberuwa, Gray L B. “Development of sindbis virus as an oncolytic agent.” 2012. Doctoral Dissertation, University of Oxford. Accessed April 14, 2021. http://ora.ox.ac.uk/objects/uuid:d9737357-ab86-4baf-92a9-b4a21b615fd7 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580968.

MLA Handbook (7th Edition):

Kueberuwa, Gray L B. “Development of sindbis virus as an oncolytic agent.” 2012. Web. 14 Apr 2021.

Vancouver:

Kueberuwa GLB. Development of sindbis virus as an oncolytic agent. [Internet] [Doctoral dissertation]. University of Oxford; 2012. [cited 2021 Apr 14]. Available from: http://ora.ox.ac.uk/objects/uuid:d9737357-ab86-4baf-92a9-b4a21b615fd7 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580968.

Council of Science Editors:

Kueberuwa GLB. Development of sindbis virus as an oncolytic agent. [Doctoral Dissertation]. University of Oxford; 2012. Available from: http://ora.ox.ac.uk/objects/uuid:d9737357-ab86-4baf-92a9-b4a21b615fd7 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580968


Virginia Tech

27. Raghunath, Shobana. Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer.

Degree: PhD, Biomedical and Veterinary Sciences, 2012, Virginia Tech

 Prostate cancer (CaP) is the second leading cause of cancer related deaths in men in the United States. Currently, androgen depletion is an essential strategy… (more)

Subjects/Keywords: Tumor initiating cells; Prostate cancer stem cells; Oncolytic virotherapy; Newcastle disease virus; Re targeting; Prostate specific antigen

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Raghunath, S. (2012). Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/77985

Chicago Manual of Style (16th Edition):

Raghunath, Shobana. “Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer.” 2012. Doctoral Dissertation, Virginia Tech. Accessed April 14, 2021. http://hdl.handle.net/10919/77985.

MLA Handbook (7th Edition):

Raghunath, Shobana. “Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer.” 2012. Web. 14 Apr 2021.

Vancouver:

Raghunath S. Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer. [Internet] [Doctoral dissertation]. Virginia Tech; 2012. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10919/77985.

Council of Science Editors:

Raghunath S. Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer. [Doctoral Dissertation]. Virginia Tech; 2012. Available from: http://hdl.handle.net/10919/77985

28. Leddon, Jennifer. Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma.

Degree: PhD, Medicine: Immunology, 2015, University of Cincinnati

 Multiple studies have indicated that in addition to direct oncolysis, virotherapy promotes an antitumor cytotoxic T cell response important for efficacy. To study this phenomenon… (more)

Subjects/Keywords: Immunology; sarcoma; immunotherapy; oncolytic; virotherapy; HSV

oncolytic virotherapy—or the use of live naturally non-pathogenic or attenuated viruses to infect… …of oncolytic HSV virotherapy has been demonstrated in a variety of adult and pediatric… …interferon response. The delivery of therapeutic genes by oncolytic virotherapy has tremendous… …tumor responses to oncolytic HSV therapy in immunocompetent and… …recognition. [105, 106]. Oncolytic Herpes Simplex Virus Therapy The concept of using… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leddon, J. (2015). Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1427980753

Chicago Manual of Style (16th Edition):

Leddon, Jennifer. “Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma.” 2015. Doctoral Dissertation, University of Cincinnati. Accessed April 14, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1427980753.

MLA Handbook (7th Edition):

Leddon, Jennifer. “Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma.” 2015. Web. 14 Apr 2021.

Vancouver:

Leddon J. Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma. [Internet] [Doctoral dissertation]. University of Cincinnati; 2015. [cited 2021 Apr 14]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1427980753.

Council of Science Editors:

Leddon J. Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma. [Doctoral Dissertation]. University of Cincinnati; 2015. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1427980753


University of Florida

29. Jacobsen, Karly A. A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus.

Degree: PhD, Mathematics, 2013, University of Florida

Oncolytic virotherapy is a tumor treatment which uses viruses to selectively target and destroy cancer cells. Clinical trials have demonstrated varying degrees of success for the… (more)

Subjects/Keywords: Budding; Cancer; Mathematical models; Mathematics; Numerical methods; Oncolytic viruses; Ordinary differential equations; Syncytia; Tumors; Uniqueness; advection  – boundary  – cancer  – differential  – diffusion  – equations  – mathematical  – model  – moving  – oncolytic  – syncytia  – tumor  – virotherapy  – virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jacobsen, K. A. (2013). A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus. (Doctoral Dissertation). University of Florida. Retrieved from https://ufdc.ufl.edu/UFE0045381

Chicago Manual of Style (16th Edition):

Jacobsen, Karly A. “A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus.” 2013. Doctoral Dissertation, University of Florida. Accessed April 14, 2021. https://ufdc.ufl.edu/UFE0045381.

MLA Handbook (7th Edition):

Jacobsen, Karly A. “A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus.” 2013. Web. 14 Apr 2021.

Vancouver:

Jacobsen KA. A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus. [Internet] [Doctoral dissertation]. University of Florida; 2013. [cited 2021 Apr 14]. Available from: https://ufdc.ufl.edu/UFE0045381.

Council of Science Editors:

Jacobsen KA. A Mathematical Model for Tumor Therapy with a Fusogenic Oncolytic Virus. [Doctoral Dissertation]. University of Florida; 2013. Available from: https://ufdc.ufl.edu/UFE0045381

30. Odom, Carl Irwin. Down-modulation of MICA on malignant glioma cells by herpes simplex virus.

Degree: MS, 2012, University of Alabama – Birmingham

Glioblastoma Multiforme is a primary malignancy of the central nervous system and is fatal for patients despite surgical resection and radiotherapy. Oncolytic Herpes Simplex Virus… (more)

Subjects/Keywords: Down-Regulation<; br>; Glioblastoma – therapy <; br>; Killer Cells, Natural – immunology<; br>; Oncolytic Virotherapy <; br>; Simplexvirus – metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Odom, C. I. (2012). Down-modulation of MICA on malignant glioma cells by herpes simplex virus. (Masters Thesis). University of Alabama – Birmingham. Retrieved from http://contentdm.mhsl.uab.edu/u?/etd,1373

Chicago Manual of Style (16th Edition):

Odom, Carl Irwin. “Down-modulation of MICA on malignant glioma cells by herpes simplex virus.” 2012. Masters Thesis, University of Alabama – Birmingham. Accessed April 14, 2021. http://contentdm.mhsl.uab.edu/u?/etd,1373.

MLA Handbook (7th Edition):

Odom, Carl Irwin. “Down-modulation of MICA on malignant glioma cells by herpes simplex virus.” 2012. Web. 14 Apr 2021.

Vancouver:

Odom CI. Down-modulation of MICA on malignant glioma cells by herpes simplex virus. [Internet] [Masters thesis]. University of Alabama – Birmingham; 2012. [cited 2021 Apr 14]. Available from: http://contentdm.mhsl.uab.edu/u?/etd,1373.

Council of Science Editors:

Odom CI. Down-modulation of MICA on malignant glioma cells by herpes simplex virus. [Masters Thesis]. University of Alabama – Birmingham; 2012. Available from: http://contentdm.mhsl.uab.edu/u?/etd,1373

[1] [2]

.